Foundations
Gastric cancer comprises clinically and biologically distinct disease presentations. Histology, stage and molecular features can influence management.
Diagnostics
Pathology, imaging, laboratory findings and, where appropriate, molecular diagnostics are assessed together.
Biomarkers
Treatment-relevant biomarkers depend on tumour type, disease stage, previous therapy and the clinical question.
Treatment course
Surgery, radiotherapy, systemic therapy, immunotherapy and supportive measures can be documented chronologically.
Immune profile and tumour dynamics
Additional longitudinal data can be recorded in a structured way but do not replace established response assessment.
Medical notice: This content is for information and evidence orientation only and does not replace medical diagnosis or treatment decisions.